Stock Events

Stock Events

Recursion Pharmaceuticals (RXRX) Q2 2026 Earnings

6MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.52

-0.42

-0.32

-0.22

Details

Expected EPS

-0.265

Actual EPS

-0.22

Surprise EPS

0.05

Surprise Percent

+16.98%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.22 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.